CNN

Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all

Demand for Wegovy and other GLP-1 drugs used to treat obesity and diabetes has skyrocketed, but a new report suggests that many people may not be sticking with their weight-loss treatment long enough.
CNN

More people with type 1 diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
Glamour

It Feels Like Everyone Is Using a GLP-1 to Lose 10 or 15 Pounds—Should I?

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...
Medscape

Use of GLP-1s in Type 1 Diabetes Not Linked to Increased DKA

LAS VEGAS — Off-label use of GLP-1 drugs by people with type 1 diabetes (T1D) did not lead to diabetic ketoacidosis (DKA) or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist ...